Mauna Kea Technologies SAS reported consolidated sales results for the year ended December 31, 2013. For the year, the company reported total sales of EUR 9,977,000 against EUR 8,809,000 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.387 EUR | -0.26% |
|
+2.79% | -17.83% |
06-27 | The same old winners | ![]() |
06-26 | Mauna Kea Technologies SA Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.83% | 26.02M | |
-30.79% | 15.65B | |
-57.58% | 2.09B | |
+19.25% | 1.88B | |
-18.17% | 1.36B | |
+25.65% | 1.28B | |
+2.06% | 798M | |
-33.66% | 762M | |
-36.55% | 724M | |
-30.00% | 586M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies SAS Reports Consolidated Sales Results for the Year Ended December 31, 2013